Amarantus' Presentations - AAIC Meeting, July 12-17, 2014 in Copenhagen, Denmark

Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Clinical Performance of the LymPro Assay

P2-389
11:45am - 2:15pm
Mon, Jul 14


Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Analytical Performance of the LymPro Assay

P3-117
11:45am - 2:15pm
Tue, Jul 15


Retrospective Analysis of Clinical Prognosis of Subjects from a 2005 study using the LymPro assay

P3-118
11:45am - 2:15pm
Tue, Jul 15


Great time to announce a "big pharma" marketing partnership for LymPro. Roche in the E.U. and Quest Diagnostics in the U.S. would make great partners.

Stay tuned for news.

Note: Jason Napadano tweeted that his next article on Amarantus would be after the AAIC meeting.


Twitter: @AmarantusBio .... 9,955 followers.


p.s. Expecting the share price to move substantially higher from here through the up-listing in 4Q2014. Major milestones ahead.